NorthWest Biotherapeutics Inc (NWBO)

[VMLG17]

The 10Q states, “The Ancillary Services Agreement had an original term of eight months, which ended in July 2020. The Company extended the term by 12 months to July 2021 and another 12 months to July 2022, with no other changes, and recently extended it for another 12 months to July 2023.” It seems to me that these agreements have consistently been renewed for 12-month periods as a formality with the previous one expiring July 2022. I don’t believe it’s a reasonable inference to conclude that the SOWs won’t be completed until the next expiration date of July 2023.